HOME > Business Wire > Article
Toyoda Gosei Accelerates Development of Motorcycle Airbag with Vehicle Crash Test
KIYOSU, Japan--( BUSINESS WIRE )-- Toyoda Gosei Co., Ltd. (TOKYO:7282) is leveraging its expertise in safety systems for automobiles to develop an airbag for motorcycles as a part of the company’s efforts for safer mobility in society. Aiming for an early market launch, it has recently conducted a crash test in-house with real vehicles. The findings obtained in this test are being used to refine the company’s motorcycle rider protection technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610421427/en/

Motorcycle crash test
Toyoda Gosei is planning and developing safety products for each form of mobility as it seeks to “provide safety to everyone on the move.” Globally, about 360,000 riders of powered two-wheelers and three-wheelers lose their lives each year in traffic accidents.* Protecting them is a crucial issue for the company. Thus, it is working to launch an airbag with high protection performance that can be fitted in the limited space of motorcycles.
In the recent test, the company examined how the airbag deployed in a motorcycle frontal collision, and how it protected the rider. The situation of motorcycle riders differs from that of drivers and passengers in automobile cabins during collisions. Going forward, Toyoda Gosei will utilize real environment tests and simulation technology as it continues to develop airbags that can overcome the difficulties of protecting motorcycle riders.
* Based on 2021 data from Global status report on road safety issued by the World Health Organization.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610421427/en/
Source: Toyoda Gosei Co., Ltd.
Business Wire
-
06/11 13:00 Capcom’s Street Fighter 6 Sales Surpass 5 Million Units Worldwide!
-
06/11 10:58 Hibiki Path Advisors Finalized Its Policy to Oppose ① the Proposed T...
-
06/11 10:00 Ares Management Closes Inaugural US$2.4 Billion Data Center Developmen...
-
06/11 08:00 3D Investment Partners: Leading Proxy Advisory Firm Glass Lewis Recomm...
-
06/11 04:00 Toyoda Gosei Accelerates Development of Motorcycle Airbag with Vehicle...
-
06/11 02:00 Blue Planet Prize 2025: Announcement of Prize Laureates
-
06/10 23:00 RGA and SOA Research Institute Release Comprehensive Study on Retireme...
-
06/10 12:35 Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascula...
-
06/10 12:00 Renesas Brings USB-C Rev. 2.4 Support to New Ultra-Low-Power RA2L2 Mic...
-
06/10 12:00 New Study Finds Masimo SedLine® Brain Function Monitoring Offers Sign...
-
06/10 11:30 Leading Independent Proxy Advisory Firm ISS Recommends Shareholders El...
-
06/10 10:00 C Spire Leverages Netcracker’s GenAI Capabilities for Improved Custo...
-
06/10 08:00 Faraday Unveils FlashKit™-22RRAM: An eNVM-Based SoC Development Plat...
-
06/10 06:30 3D Investment Partners Recommends Shareholders of Nippon Steel to Vote...
-
06/10 03:00 Mitsubishi Electric’s ME Innovation Fund Invests in Carbon Credit Mo...
-
06/10 02:07 WEAVE LIVING and KKR Build on Strategic Partnership with Acquisition o...
-
06/10 01:00 Renesas Announces Executive Leadership Team Appointment
-
06/09 14:00 mesm Tokyo, Autograph Collection: Afternoon Exhibition Chapter 14 "Thi...
-
06/09 13:00 Capcom’s Resident Evil Requiem, the Latest Title in the Series, Set ...
-
06/09 12:32 Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlightin...
-
06/09 12:00 DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Li...
-
06/09 06:00 Mitsubishi Electric to Conduct Demonstration Using CO2 Capture Machine...
-
06/08 23:30 SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an ...
-
06/08 21:18 SQUARE ENIX Brings FINAL FANTASY XVI and FINAL FANTASY VII REMAKE to X...
-
06/06 20:30 Natuzzi Will Be Present at the Expo 2025 Osaka With Its Collections
-
06/06 16:27 JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of...
-
06/06 10:00 Otsuka Sibeprenlimab Phase 3 Data Show a Statistically Significant and...
-
06/06 01:01 JETRO and CIC to Showcase Promising Japanese Biotech Startups at "Japa...
-
06/05 20:00 BGO Announces US$5.1 Billion Capital Raise for Its Asia Value-Add Real...
-
06/05 14:00 Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Pa...